BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8208756)

  • 1. Corticotropin-releasing factor and schedule-induced polydipsia.
    Cole BJ; Koob GF
    Pharmacol Biochem Behav; 1994 Mar; 47(3):393-8. PubMed ID: 8208756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine pretreatment alleviates suppression of schedule-controlled responding produced by corticotropin releasing factor (CRF) in rats.
    Ahlers ST; Salander MK; Shurtleff D; Thomas JR
    Brain Res Bull; 1992 Nov; 29(5):567-71. PubMed ID: 1422854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of repeated administration of corticotropin-releasing factor on schedule-controlled behavior in rats.
    Ahlers ST; Salander MK
    Pharmacol Biochem Behav; 1993 Feb; 44(2):375-80. PubMed ID: 8446669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perturbations in Effort-Related Decision-Making Driven by Acute Stress and Corticotropin-Releasing Factor.
    Bryce CA; Floresco SB
    Neuropsychopharmacology; 2016 Jul; 41(8):2147-59. PubMed ID: 26830960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats.
    Heinrichs SC; Koob GF
    Psychopharmacology (Berl); 1992; 109(1-2):177-84. PubMed ID: 1365653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.
    Britton KT; Lee G; Vale W; Rivier J; Koob GF
    Brain Res; 1986 Mar; 369(1-2):303-6. PubMed ID: 3008937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
    Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
    Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-related effects of CRF and CRF-derived peptides: dissociation of behavioral, endocrine and autonomic activity.
    Diamant M; de Wied D
    Neuroendocrinology; 1993 Jun; 57(6):1071-81. PubMed ID: 8232765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permissive role of corticotropin-releasing factor in the acute stress-induced prolactin release in female rats.
    Akema T; Chiba A; Oshida M; Kimura F; Toyoda J
    Neurosci Lett; 1995 Sep; 198(2):146-8. PubMed ID: 8592642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice.
    Berridge CW; Dunn AJ
    Horm Behav; 1987 Sep; 21(3):393-401. PubMed ID: 3499373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
    Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
    Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse strain differences in the behavioral effects of corticotropin-releasing factor (CRF) and the CRF antagonist alpha-helical CRF9-41.
    Conti LH; Costello DG; Martin LA; White MF; Abreu ME
    Pharmacol Biochem Behav; 1994 Jun; 48(2):497-503. PubMed ID: 8090821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-helical CRF blocks differential influence of corticotropin releasing factor (CRF) on appetitive and aversive memory retrieval in rats.
    Kumar KB; Karanth KS
    J Neural Transm (Vienna); 1996; 103(8-9):1117-26. PubMed ID: 9013399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of endogenous corticotropin-releasing factor (CRF) in the mediation of the behavioral action of cocaine in rats.
    Sarnyai Z; Höhn J; Szabó G; Penke B
    Life Sci; 1992; 51(26):2019-24. PubMed ID: 1335535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks CRF- and stress-related alterations of gastric and colonic motor function.
    Martínez V; Rivier J; Wang L; Taché Y
    J Pharmacol Exp Ther; 1997 Feb; 280(2):754-60. PubMed ID: 9023288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.
    Dagnault A; Ouerghi D; Richard D
    Brain Res Bull; 1993; 32(6):689-92. PubMed ID: 8221168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
    J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
    Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
    Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure.
    Thorsell A; Slawecki CJ; Ehlers CL
    Behav Brain Res; 2005 Jun; 161(1):133-40. PubMed ID: 15904720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats.
    Diamant M; de Wied D
    Endocrinology; 1991 Jul; 129(1):446-54. PubMed ID: 2055199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.